Amy T. Waldman, M.D., M.S.C.E., is an Assistant Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania (Penn).  Dr. Waldman received her Medical Doctorate from Jefferson Medical College (Thomas Jefferson University). She completed her pediatrics residency at The Children’s Hospital of Philadelphia (CHOP) and child neurology residency at both CHOP and the Hospital of the University of Pennsylvania. In 2005, she co-founded the Pediatric MS Center at CHOP, and in 20145, she co-founded the Leukodystrophy Center of Excellence at The Children's Hospital of Philadelphia, where she now serves as the Medical Director.  The recipient of the National Multiple Sclerosis Society-American Academy of Neurology Foundation (now the American Brain Foundation) Clinician Scientist Development Award, Dr. Waldman completed a fellowship in pediatric and adult MS at CHOP and the Hospital of the University of Pennsylvania. During her fellowship, she obtained a Master of Science in Clinical Epidemiology degree at Penn.

Dr. Waldman’s primary research focuses on the development and interpretation of outcome measures for clinical trials in neuroinflammatory and neurodegenerative diseases. She has received funding from the NIH to study visual function and axonal loss through imaging in children with multiple sclerosis. Her work has also highlighted differences between pediatric and adult-onset MS. She is also a site principal investigator for collaborative funded research projects with other pediatric MS centers throughout the United States and Canada, including UTSW. Her research as been published in Neurology, Multiple Sclerosis and Related Disorders, Multiple Sclerosis International, Journal of the American Association for Pediatric Ophthalmology and Strabismus, Journal of Child Neurology and others.  She has authored numerous book chapters on the clinical features, treatment, and prognosis of CNS demyelination. In 2015, she extended her expertise in clinical outcome measures to the leukodystrophies, with the goal of assisting in clinical trial design and interpretation for these disorders. She is leading a natural history study on Alexander disease, including collecting data on performance-based outcome measures in affected individuals. As a member of the Global Leukodystrophy Initiative (GLIA), she is an active participant on their history and biorepository task forces. She is the co-director of the neuroepidemiology course at the Center for Clinical Epidemiology and Biostatistics at Penn and a faculty mentor for multiple clinical and research programs at CHOP and Penn. She previously served as the treasurer of the Child Neurology Foundation, and a scientific advisor for The Calliope Joy Foundation. She is the co-lead of the Pediatric Demyelinating Group of the International Women in MS group. She is also a member of the International Pediatric Multiple Sclerosis Study Group (IPMSSG), International MS Visual System Consortium (IMSVISUAL), American Academy of Neurology, Child Neurology Society, and Clinical Advisory Committee for the National Multiple Sclerosis Society's Greater Delaware Valley Chapter.